Educational Resource
This guide describes common diagnostic panels for informational purposes only. Panel selection, ordering, and interpretation are the responsibility of your licensed healthcare provider. Results must always be reviewed in the context of your complete medical history.
What Is a Diagnostic Panel?
A diagnostic panel is a predefined group of laboratory tests ordered together because they collectively assess a specific organ system, physiological process, or health risk. Panels are more efficient than ordering individual tests one at a time because a single blood draw can provide results for all components simultaneously, reducing patient inconvenience, lowering per-test costs, and giving physicians a more complete clinical picture. The components of each panel are standardized, meaning the same tests are included wherever the panel is ordered across the country.
Panels are designed to be interpreted holistically: understanding how individual components relate to each other often provides more diagnostic value than any single measurement alone. For example, evaluating ALT and AST together with bilirubin and albumin paints a more complete picture of liver function than any of those values individually.
Comprehensive Metabolic Panel (CMP)
The Comprehensive Metabolic Panel is the most broadly ordered chemical screening panel in outpatient medicine. It includes fourteen individual measurements that together assess kidney function, electrolyte balance, blood glucose, acid-base status, and liver function in one panel. The CMP is routinely ordered as part of annual wellness exams, pre-operative screening, and monitoring of patients taking medications that may affect kidney or liver function.
The fourteen components are: glucose, calcium, sodium, potassium, carbon dioxide (bicarbonate), chloride, blood urea nitrogen (BUN), creatinine, estimated glomerular filtration rate (eGFR), total protein, albumin, total bilirubin, alkaline phosphatase (ALP), alanine aminotransferase (ALT), and aspartate aminotransferase (AST). The kidney-related markers (BUN, creatinine, eGFR) reflect the kidneys' ability to filter waste products from the blood. The liver markers (total protein, albumin, bilirubin, ALP, ALT, AST) reflect hepatic integrity and synthetic function. The electrolytes (sodium, potassium, chloride, CO2) reflect fluid balance and acid-base regulation.
Basic Metabolic Panel (BMP)
The Basic Metabolic Panel is a subset of the CMP, containing eight components that focus on kidney function, electrolyte balance, and blood sugar without the liver function tests. It is commonly ordered for patients being monitored for electrolyte disturbances, dehydration, kidney disease, diabetes management, and medication monitoring such as patients taking diuretics or angiotensin-converting enzyme inhibitors.
The BMP components are: glucose, calcium, sodium, potassium, carbon dioxide, chloride, BUN, and creatinine. Because it excludes the liver function markers, the BMP provides a faster, focused snapshot of metabolic and renal status. Many emergency departments use the BMP for rapid assessment of critically ill patients where time is essential.
Lipid Panel
The lipid panel is the cornerstone of cardiovascular risk assessment. It measures four key fats in the bloodstream: total cholesterol, LDL (low-density lipoprotein) cholesterol, HDL (high-density lipoprotein) cholesterol, and triglycerides. Some versions also report VLDL (very-low-density lipoprotein) cholesterol and non-HDL cholesterol, both of which provide additional cardiovascular risk information. The lipid panel is typically performed after a minimum nine-hour fast to ensure triglyceride values are not artificially elevated by a recent meal.
Physicians use lipid panel results alongside age, sex, blood pressure, smoking status, and diabetes history to calculate a patient's ten-year cardiovascular disease risk score. This calculation guides decisions about lifestyle modifications and pharmacologic interventions such as statin therapy. Annual lipid panel monitoring is often recommended for patients already on lipid-lowering medication.
Thyroid Panel
A thyroid panel assesses the function of the thyroid gland, a butterfly-shaped organ in the neck that produces hormones regulating metabolism, heart rate, body temperature, and energy levels. The standard thyroid panel includes TSH (thyroid-stimulating hormone), Free T4 (free thyroxine), and Free T3 (free triiodothyronine). TSH is the most sensitive first-line test: it rises when the thyroid produces too little hormone and falls when it produces too much. The expanded panel with Free T4 and Free T3 provides a more complete picture of thyroid hormone availability in the body.
Thyroid panels are ordered when symptoms such as fatigue, unexplained weight changes, cold intolerance, hair thinning, or palpitations suggest thyroid dysfunction. Anti-thyroid antibody tests (anti-TPO, anti-Tg) may be added when autoimmune thyroid disease is suspected. TSH monitoring every six to twelve months is standard for patients already receiving thyroid hormone replacement therapy.
Liver Function Panel
The liver function panel focuses specifically on hepatic health and includes measurements of ALT, AST, ALP, GGT (gamma-glutamyl transferase), total bilirubin, direct bilirubin, total protein, and albumin. ALT and AST are intracellular liver enzymes that leak into the bloodstream when hepatocytes are injured, making them sensitive markers of acute or chronic liver cell damage. ALP and GGT elevation suggests biliary obstruction or cholestatic liver disease. Bilirubin, a byproduct of hemoglobin breakdown, rises when the liver cannot process it efficiently. Albumin and total protein reflect the liver's synthetic capacity, which diminishes in advanced chronic liver disease.
Kidney Function Panel
The kidney function panel, sometimes called the renal function panel, focuses on how well the kidneys filter waste and regulate fluid and electrolyte balance. Core components include BUN, creatinine, eGFR (estimated glomerular filtration rate), uric acid, and electrolytes. eGFR is calculated from serum creatinine, age, and sex and provides an estimate of how many milliliters of blood the kidneys filter per minute per 1.73 square meters of body surface area. Declining eGFR over time is a key indicator of progressive chronic kidney disease. The kidney function panel is essential for patients with hypertension, diabetes, or known kidney disease, and for monitoring medications that are renally cleared or nephrotoxic.
Choosing the Right Panel
Your physician selects the appropriate panel based on your clinical presentation, medical history, risk factors, and the purpose of the evaluation. Routine wellness screening typically begins with the CMP and CBC. Patients with specific risk factors or symptoms may need targeted panels such as a lipid panel for cardiovascular risk assessment or a thyroid panel for metabolic symptoms. Patients managing chronic conditions typically require regular panel monitoring to track disease progression and treatment response. Always discuss with your provider which panels are appropriate for your individual situation and what the results mean in your specific context.